Learn More
BCAR3 Polyclonal Antibody, Bethyl Laboratories
Rabbit Polyclonal Antibody
Supplier: Bethyl Laboratories, Inc A301671AT
Description
The recommended shelf life for this product is 1 year from date of receipt.
Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48.Specifications
| BCAR3 | |
| Polyclonal | |
| TBS with 0.1% BSA and 0.09% sodium azide | |
| O75815 | |
| BCAR3 | |
| Between 25 and 75 | |
| 20 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Western Blot | |
| Unconjugated | |
| BCAR3 | |
| BCAR3; NSP2; SH2D3B; breast cancer anti-estrogen resistance 3; KIAA0554; OTTHUMP00000011961; breast cancer antiestrogen resistance 3; dJ1033H22.2 (breast cancer anti-estrogen resistance 3) | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 8412 | |
| 4° C | |
| Liquid |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.